| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Elisa Ramos-Sevillano | Q84790015 |
| Giuseppe Ercoli | Q86828979 | ||
| P2093 | author name string | Jeremy S Brown | |
| P2860 | cites work | Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine | Q22250891 |
| Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci | Q24548662 | ||
| PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES | Q24681118 | ||
| Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? | Q24809188 | ||
| Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes | Q25256120 | ||
| T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice | Q27346256 | ||
| Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates | Q28258300 | ||
| Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency | Q28306462 | ||
| The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya | Q28731923 | ||
| Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation | Q28744146 | ||
| Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome | Q29614595 | ||
| Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies | Q33312893 | ||
| Interleukin-17A mediates acquired immunity to pneumococcal colonization | Q33370537 | ||
| Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense | Q33788735 | ||
| T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization | Q33820413 | ||
| Efficacy of pneumococcal conjugate vaccines in large scale field trials | Q33899670 | ||
| CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization | Q33935327 | ||
| Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. | Q33996628 | ||
| Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model | Q34033275 | ||
| Impaired CD4 T cell memory response to Streptococcus pneumoniae precedes CD4 T cell depletion in HIV-infected Malawian adults | Q34043394 | ||
| Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae | Q34121334 | ||
| The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice | Q34164122 | ||
| Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage | Q34229627 | ||
| Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders | Q34230483 | ||
| The primary immunodeficiencies | Q34300415 | ||
| Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide | Q34492821 | ||
| Infections in 252 patients with common variable immunodeficiency | Q34590662 | ||
| Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung | Q34649770 | ||
| Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study | Q34740228 | ||
| Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant | Q34760949 | ||
| Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study | Q34803614 | ||
| The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms | Q35015208 | ||
| The role of host and microbial factors in the pathogenesis of pneumococcal bacteraemia arising from a single bacterial cell bottleneck. | Q35126697 | ||
| Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses | Q35154329 | ||
| Pneumonias: Their Management. | Q35565442 | ||
| Acquisition of pneumococci specific effector and regulatory Cd4+ T cells localising within human upper respiratory-tract mucosal lymphoid tissue. | Q35586932 | ||
| Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. | Q35784046 | ||
| TNF Drives Monocyte Dysfunction with Age and Results in Impaired Anti-pneumococcal Immunity. | Q35894071 | ||
| Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes | Q35927343 | ||
| Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country | Q36013814 | ||
| Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage | Q36018177 | ||
| Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens | Q36263931 | ||
| Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins | Q36313904 | ||
| Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives | Q36349143 | ||
| Pneumococcal colonization in older adults | Q36454231 | ||
| Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway | Q36804267 | ||
| Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults | Q36999810 | ||
| Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice | Q37241352 | ||
| Impaired innate mucosal immunity in aged mice permits prolonged Streptococcus pneumoniae colonization. | Q37336016 | ||
| Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens | Q37363266 | ||
| Cross-protective mucosal immunity mediated by memory Th17 cells against Streptococcus pneumoniae lung infection. | Q37372514 | ||
| Diverse evolutionary patterns of pneumococcal antigens identified by pangenome-wide immunological screening | Q37598959 | ||
| Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage | Q37675714 | ||
| Streptococcus pneumoniae Transmission Is Blocked by Type-Specific Immunity in an Infant Mouse Model | Q37700060 | ||
| Dysregulated inflammation as a risk factor for pneumonia in the elderly | Q37979794 | ||
| Adult pneumococcal vaccination: advances, impact, and unmet needs | Q38757344 | ||
| Pneumococcal Capsular Polysaccharide Immunity in the Elderly | Q38861144 | ||
| Prevalence and antibiotic resistance of commensal Streptococcus pneumoniae in nine European countries | Q38865824 | ||
| Protective Efficacy of Pneumococcal Polysaccharide Vaccines | Q39172835 | ||
| Antibody-based therapies for emerging infectious diseases | Q39228846 | ||
| Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. | Q39392994 | ||
| The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. | Q39910189 | ||
| Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization | Q40017980 | ||
| Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia. | Q40209420 | ||
| Serum therapy revisited: animal models of infection and development of passive antibody therapy | Q40286009 | ||
| Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden | Q40595069 | ||
| THERAPEUTIC SERUM FOR PNEUMOCOCCUS TYPE V (COOPER) PNEUMONIA | Q40924199 | ||
| Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. | Q41415380 | ||
| Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children. | Q41827353 | ||
| THE MECHANISM OF THE CURATIVE ACTION OF ANTIPNEUMOCOCCUS SERUM. | Q42127916 | ||
| Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model | Q42171376 | ||
| Antibody blocks acquisition of bacterial colonization through agglutination | Q42209061 | ||
| The immune response to pneumococcal proteins during experimental human carriage | Q42944608 | ||
| T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease | Q43645903 | ||
| Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage | Q44786977 | ||
| Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study | Q45011370 | ||
| Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination | Q45738385 | ||
| Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status | Q46846171 | ||
| Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. | Q50651452 | ||
| A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. | Q51808487 | ||
| Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. | Q51989389 | ||
| Nasopharyngeal Exposure to Streptococcus pneumoniae Induces Extended Age-Dependent Protection against Pulmonary Infection Mediated by Antibodies and CD138+ Cells. | Q55633626 | ||
| The current burden of pneumococcal disease in England and Wales | Q57385772 | ||
| A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting | Q57385775 | ||
| Antibody Responses to Nasopharyngeal Carriage ofStreptococcus pneumoniaein Adults: A Longitudinal Household Study | Q57385776 | ||
| Effectiveness of Immunoglobulin Replacement Therapy on Clinical Outcome in Patients with Primary Antibody Deficiencies: Results from a Multicenter Prospective Cohort Study | Q57716617 | ||
| Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization among Immunized and Unimmunized Children in a Community‐Randomized Trial | Q58097261 | ||
| Lack of pneumococcal carriage in the hospitalised elderly | Q61911776 | ||
| Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae | Q73688169 | ||
| Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children | Q78300868 | ||
| Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age > or = 65 | Q79188296 | ||
| Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease | Q81253191 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bacterial antibodies | Q68926611 |
| P304 | page(s) | 358 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Mechanisms of Naturally Acquired Immunity to Streptococcus pneumoniae | |
| P478 | volume | 10 |
| Q89622601 | Assessment of an Antibody-in-Lymphocyte Supernatant Assay for the Etiological Diagnosis of Pneumococcal Pneumonia in Children |
| Q99609312 | Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections |
| Q90602359 | Immunologic Dysfunction Contributes to the Otitis Prone Condition |
| Q103027596 | Mechanism and inhibition of Streptococcus pneumoniae IgA1 protease |
| Q101119499 | Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children |
| Q92994191 | Pneumonia recovery reprograms the alveolar macrophage pool |
Search more.